http://streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 16 Jun 2026 21:22:44 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Equity+Offerings/SOPHiA+Genetics+prices+%2450M+public+offering+at+%244.75+per+share/26655798.html <p>SOPHiA Genetics (NASDAQ: SOPH) has priced an underwritten public offering of 10,526,000 ordinary shares at $4.75 per share, with gross proceeds expected to reach approximately $50 million before underwriting discounts, commissions, and other expenses, according to a press release.</p> <p>All shares in the offering will be sold by the company. SOPHiA Genetics has also granted underwriters a 30-day option to purchase up to 1,578,900 additional ordinary shares at the public offering price, less underwriting discounts and commissions.</p> <p>The offering is expected to close on June 18, 2026, subject to customary closing conditions.</p> <p>TD Cowen is acting as lead book-running manager for the offering. http://www.streetinsider.com/Equity+Offerings/SOPHiA+Genetics+prices+%2450M+public+offering+at+%244.75+per+share/26655798.html Tue, 16 Jun 2026 21:22:44 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/Equity+Offerings/SOPHiA+Genetics+prices+%2450M+public+offering+at+%244.75+per+share/26655798.html <p>SOPHiA Genetics (NASDAQ: SOPH) has priced an underwritten public offering of 10,526,000 ordinary shares at $4.75 per share, with gross proceeds expected to reach approximately $50 million before underwriting discounts, commissions, and other expenses, according to a press release.</p> <p>All shares in the offering will be sold by the company. SOPHiA Genetics has also granted underwriters a 30-day option to purchase up to 1,578,900 additional ordinary shares at the public offering price, less underwriting discounts and commissions.</p> <p>The offering is expected to close on June 18, 2026, subject to customary closing conditions.</p> <p>TD Cowen is acting as lead book-running manager for the offering. http://www.streetinsider.com/Equity+Offerings/SOPHiA+Genetics+prices+%2450M+public+offering+at+%244.75+per+share/26655798.html Tue, 16 Jun 2026 21:22:44 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/Equity+Offerings/SOPHiA+Genetics+prices+%2450M+public+offering+at+%244.75+per+share/26655798.html <p>SOPHiA Genetics (NASDAQ: SOPH) has priced an underwritten public offering of 10,526,000 ordinary shares at $4.75 per share, with gross proceeds expected to reach approximately $50 million before underwriting discounts, commissions, and other expenses, according to a press release.</p> <p>All shares in the offering will be sold by the company. SOPHiA Genetics has also granted underwriters a 30-day option to purchase up to 1,578,900 additional ordinary shares at the public offering price, less underwriting discounts and commissions.</p> <p>The offering is expected to close on June 18, 2026, subject to customary closing conditions.</p> <p>TD Cowen is acting as lead book-running manager for the offering. http://www.streetinsider.com/Equity+Offerings/SOPHiA+Genetics+prices+%2450M+public+offering+at+%244.75+per+share/26655798.html Tue, 16 Jun 2026 21:22:44 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/Equity+Offerings/SOPHiA+Genetics+prices+%2450M+public+offering+at+%244.75+per+share/26655798.html <p>SOPHiA Genetics (NASDAQ: SOPH) has priced an underwritten public offering of 10,526,000 ordinary shares at $4.75 per share, with gross proceeds expected to reach approximately $50 million before underwriting discounts, commissions, and other expenses, according to a press release.</p> <p>All shares in the offering will be sold by the company. SOPHiA Genetics has also granted underwriters a 30-day option to purchase up to 1,578,900 additional ordinary shares at the public offering price, less underwriting discounts and commissions.</p> <p>The offering is expected to close on June 18, 2026, subject to customary closing conditions.</p> <p>TD Cowen is acting as lead book-running manager for the offering. http://www.streetinsider.com/Equity+Offerings/SOPHiA+Genetics+prices+%2450M+public+offering+at+%244.75+per+share/26655798.html Tue, 16 Jun 2026 21:22:44 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/Equity+Offerings/SOPHiA+Genetics+prices+%2450M+public+offering+at+%244.75+per+share/26655798.html <p>SOPHiA Genetics (NASDAQ: SOPH) has priced an underwritten public offering of 10,526,000 ordinary shares at $4.75 per share, with gross proceeds expected to reach approximately $50 million before underwriting discounts, commissions, and other expenses, according to a press release.</p> <p>All shares in the offering will be sold by the company. SOPHiA Genetics has also granted underwriters a 30-day option to purchase up to 1,578,900 additional ordinary shares at the public offering price, less underwriting discounts and commissions.</p> <p>The offering is expected to close on June 18, 2026, subject to customary closing conditions.</p> <p>TD Cowen is acting as lead book-running manager for the offering. http://www.streetinsider.com/Equity+Offerings/SOPHiA+Genetics+prices+%2450M+public+offering+at+%244.75+per+share/26655798.html Tue, 16 Jun 2026 21:22:44 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/Equity+Offerings/SOPHiA+Genetics+prices+%2450M+public+offering+at+%244.75+per+share/26655798.html <p>SOPHiA Genetics (NASDAQ: SOPH) has priced an underwritten public offering of 10,526,000 ordinary shares at $4.75 per share, with gross proceeds expected to reach approximately $50 million before underwriting discounts, commissions, and other expenses, according to a press release.</p> <p>All shares in the offering will be sold by the company. SOPHiA Genetics has also granted underwriters a 30-day option to purchase up to 1,578,900 additional ordinary shares at the public offering price, less underwriting discounts and commissions.</p> <p>The offering is expected to close on June 18, 2026, subject to customary closing conditions.</p> <p>TD Cowen is acting as lead book-running manager for the offering. http://www.streetinsider.com/Equity+Offerings/SOPHiA+Genetics+prices+%2450M+public+offering+at+%244.75+per+share/26655798.html Tue, 16 Jun 2026 21:22:44 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/Equity+Offerings/SOPHiA+Genetics+prices+%2450M+public+offering+at+%244.75+per+share/26655798.html <p>SOPHiA Genetics (NASDAQ: SOPH) has priced an underwritten public offering of 10,526,000 ordinary shares at $4.75 per share, with gross proceeds expected to reach approximately $50 million before underwriting discounts, commissions, and other expenses, according to a press release.</p> <p>All shares in the offering will be sold by the company. SOPHiA Genetics has also granted underwriters a 30-day option to purchase up to 1,578,900 additional ordinary shares at the public offering price, less underwriting discounts and commissions.</p> <p>The offering is expected to close on June 18, 2026, subject to customary closing conditions.</p> <p>TD Cowen is acting as lead book-running manager for the offering. http://www.streetinsider.com/Equity+Offerings/SOPHiA+Genetics+prices+%2450M+public+offering+at+%244.75+per+share/26655798.html Tue, 16 Jun 2026 21:22:44 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/Equity+Offerings/SOPHiA+Genetics+prices+%2450M+public+offering+at+%244.75+per+share/26655798.html <p>SOPHiA Genetics (NASDAQ: SOPH) has priced an underwritten public offering of 10,526,000 ordinary shares at $4.75 per share, with gross proceeds expected to reach approximately $50 million before underwriting discounts, commissions, and other expenses, according to a press release.</p> <p>All shares in the offering will be sold by the company. SOPHiA Genetics has also granted underwriters a 30-day option to purchase up to 1,578,900 additional ordinary shares at the public offering price, less underwriting discounts and commissions.</p> <p>The offering is expected to close on June 18, 2026, subject to customary closing conditions.</p> <p>TD Cowen is acting as lead book-running manager for the offering. http://www.streetinsider.com/Equity+Offerings/SOPHiA+Genetics+prices+%2450M+public+offering+at+%244.75+per+share/26655798.html Tue, 16 Jun 2026 21:22:44 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/Press+Releases/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location> and ROLLE, <location value="LC/ch" idsrc="xmltag.org" >Switzerland</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:SOPH" idsrc="xmltag.org" >SOPHiA GENETICS</span> (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of <money>$4.75</money> per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately <money>$50 million</money>. All of the ordinary shares to be sold in the proposed offering will be sold http://www.streetinsider.com/Press+Releases/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html Tue, 16 Jun 2026 21:21:00 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/Press+Releases/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location> and ROLLE, <location value="LC/ch" idsrc="xmltag.org" >Switzerland</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:SOPH" idsrc="xmltag.org" >SOPHiA GENETICS</span> (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of <money>$4.75</money> per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately <money>$50 million</money>. All of the ordinary shares to be sold in the proposed offering will be sold http://www.streetinsider.com/Press+Releases/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html Tue, 16 Jun 2026 21:21:00 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/Press+Releases/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location> and ROLLE, <location value="LC/ch" idsrc="xmltag.org" >Switzerland</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:SOPH" idsrc="xmltag.org" >SOPHiA GENETICS</span> (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of <money>$4.75</money> per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately <money>$50 million</money>. All of the ordinary shares to be sold in the proposed offering will be sold http://www.streetinsider.com/Press+Releases/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html Tue, 16 Jun 2026 21:21:00 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/Press+Releases/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location> and ROLLE, <location value="LC/ch" idsrc="xmltag.org" >Switzerland</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:SOPH" idsrc="xmltag.org" >SOPHiA GENETICS</span> (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of <money>$4.75</money> per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately <money>$50 million</money>. All of the ordinary shares to be sold in the proposed offering will be sold http://www.streetinsider.com/Press+Releases/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html Tue, 16 Jun 2026 21:21:00 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/Press+Releases/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location> and ROLLE, <location value="LC/ch" idsrc="xmltag.org" >Switzerland</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:SOPH" idsrc="xmltag.org" >SOPHiA GENETICS</span> (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of <money>$4.75</money> per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately <money>$50 million</money>. All of the ordinary shares to be sold in the proposed offering will be sold http://www.streetinsider.com/Press+Releases/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html Tue, 16 Jun 2026 21:21:00 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/Press+Releases/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location> and ROLLE, <location value="LC/ch" idsrc="xmltag.org" >Switzerland</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:SOPH" idsrc="xmltag.org" >SOPHiA GENETICS</span> (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of <money>$4.75</money> per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately <money>$50 million</money>. All of the ordinary shares to be sold in the proposed offering will be sold http://www.streetinsider.com/Press+Releases/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html Tue, 16 Jun 2026 21:21:00 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/Press+Releases/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location> and ROLLE, <location value="LC/ch" idsrc="xmltag.org" >Switzerland</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:SOPH" idsrc="xmltag.org" >SOPHiA GENETICS</span> (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of <money>$4.75</money> per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately <money>$50 million</money>. All of the ordinary shares to be sold in the proposed offering will be sold http://www.streetinsider.com/Press+Releases/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html Tue, 16 Jun 2026 21:21:00 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/Press+Releases/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location> and ROLLE, <location value="LC/ch" idsrc="xmltag.org" >Switzerland</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:SOPH" idsrc="xmltag.org" >SOPHiA GENETICS</span> (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of <money>$4.75</money> per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately <money>$50 million</money>. All of the ordinary shares to be sold in the proposed offering will be sold http://www.streetinsider.com/Press+Releases/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html Tue, 16 Jun 2026 21:21:00 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/PRNewswire/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location> and ROLLE, <location value="LC/ch" idsrc="xmltag.org" >Switzerland</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:SOPH" idsrc="xmltag.org" >SOPHiA GENETICS</span> (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of <money>$4.75</money> per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately <money>$50 million</money>. All of the ordinary shares to be sold in the proposed offering will be sold http://www.streetinsider.com/PRNewswire/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html Tue, 16 Jun 2026 21:21:00 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/PRNewswire/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location> and ROLLE, <location value="LC/ch" idsrc="xmltag.org" >Switzerland</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:SOPH" idsrc="xmltag.org" >SOPHiA GENETICS</span> (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of <money>$4.75</money> per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately <money>$50 million</money>. All of the ordinary shares to be sold in the proposed offering will be sold http://www.streetinsider.com/PRNewswire/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html Tue, 16 Jun 2026 21:21:00 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/PRNewswire/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location> and ROLLE, <location value="LC/ch" idsrc="xmltag.org" >Switzerland</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:SOPH" idsrc="xmltag.org" >SOPHiA GENETICS</span> (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of <money>$4.75</money> per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately <money>$50 million</money>. All of the ordinary shares to be sold in the proposed offering will be sold http://www.streetinsider.com/PRNewswire/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html Tue, 16 Jun 2026 21:21:00 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/PRNewswire/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location> and ROLLE, <location value="LC/ch" idsrc="xmltag.org" >Switzerland</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:SOPH" idsrc="xmltag.org" >SOPHiA GENETICS</span> (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of <money>$4.75</money> per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately <money>$50 million</money>. All of the ordinary shares to be sold in the proposed offering will be sold http://www.streetinsider.com/PRNewswire/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html Tue, 16 Jun 2026 21:21:00 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/PRNewswire/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location> and ROLLE, <location value="LC/ch" idsrc="xmltag.org" >Switzerland</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:SOPH" idsrc="xmltag.org" >SOPHiA GENETICS</span> (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of <money>$4.75</money> per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately <money>$50 million</money>. All of the ordinary shares to be sold in the proposed offering will be sold http://www.streetinsider.com/PRNewswire/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html Tue, 16 Jun 2026 21:21:00 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/PRNewswire/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location> and ROLLE, <location value="LC/ch" idsrc="xmltag.org" >Switzerland</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:SOPH" idsrc="xmltag.org" >SOPHiA GENETICS</span> (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of <money>$4.75</money> per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately <money>$50 million</money>. All of the ordinary shares to be sold in the proposed offering will be sold http://www.streetinsider.com/PRNewswire/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html Tue, 16 Jun 2026 21:21:00 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/PRNewswire/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location> and ROLLE, <location value="LC/ch" idsrc="xmltag.org" >Switzerland</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:SOPH" idsrc="xmltag.org" >SOPHiA GENETICS</span> (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of <money>$4.75</money> per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately <money>$50 million</money>. All of the ordinary shares to be sold in the proposed offering will be sold http://www.streetinsider.com/PRNewswire/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html Tue, 16 Jun 2026 21:21:00 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/PRNewswire/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location> and ROLLE, <location value="LC/ch" idsrc="xmltag.org" >Switzerland</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:SOPH" idsrc="xmltag.org" >SOPHiA GENETICS</span> (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of <money>$4.75</money> per ordinary share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company are expected to be approximately <money>$50 million</money>. All of the ordinary shares to be sold in the proposed offering will be sold http://www.streetinsider.com/PRNewswire/SOPHiA+GENETICS+Announces+Pricing+of+%2450+Million+Public+Offering+of+Ordinary+Shares/26655797.html Tue, 16 Jun 2026 21:21:00 -0400 A.14185667 A.20654500 A.50100012 O.07579093 O.10874133 O.22066148 O.54189547 SOPH http://www.streetinsider.com/SEC+Filings/Form++424B5++++++SOPHiA+GENETICS+SA+++++++++++++++++++/26655314.html si-local-file:///var/storage/secattach/20260616/26655314.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++SOPHiA+GENETICS+SA+++++++++++++++++++/26655314.html Tue, 16 Jun 2026 17:24:00 -0400 O.10874133 SOPH